R1 RCM (NASDAQ:RCM) PT Lowered to $19.00
R1 RCM (NASDAQ:RCM – Get Free Report) had its price objective lowered by equities researchers at Royal Bank of Canada from $22.00 to $19.00 in a report issued on Friday, Benzinga reports. The firm presently has an “outperform” rating on the healthcare provider’s stock. Royal Bank of Canada’s target price would indicate a potential upside […]